Off-label use
The use of an FDA-approved drug for a purpose, population, or dose not specified in its approved labeling. Physicians may legally prescribe off-label. Many peptide uses in clinics are off-label.
Frequently Asked Questions
What is Off-label use?
The use of an FDA-approved drug for a purpose, population, or dose not specified in its approved labeling. Physicians may legally prescribe off-label. Many peptide uses in clinics are off-label.
Why is Off-label use important in peptide research?
Understanding off-label use is crucial for navigating the legal and regulatory landscape of peptide use. Regulatory knowledge helps practitioners and patients distinguish between approved therapies, compounded medications, and research chemicals.
Related Terms
FDA approved
A designation indicating the U.S. Food and Drug Administration has determined a drug is safe and effective for its labeled indication based on clinical trial evidence. FDA-approved peptides include semaglutide, tirzepatide, liraglutide, and PT-141.
Compounding pharmacyA pharmacy that custom-prepares medications, including peptides, based on a prescriber’s specific order. Compounded peptides are made to order rather than mass-manufactured. Regulated under 503A or 503B frameworks.